Target intelligence / Profile preview

Central and gut–brain stress-related pathways (GBA) (GBA)

Target
GBA
Molecular classification
Other
01

Overview

The central and gut–brain stress-related pathways represent a complex, bidirectional communication network that integrates the central nervous system (CNS) with the enteric nervous system (ENS) and the gastrointestinal tract (Carabotti et al., 2015, Annals of Gastroenterology). This system utilizes neural, endocrine, and immune signaling to maintain homeostasis and coordinate the body's response to psychological and physical stressors. Key mediators include the hypothalamic-pituitary-adrenal (HPA) axis and signaling molecules like corticotropin-releasing factor (CRF), which regulate gut motility, permeability, and immune function (Taché et al., 2018, Frontiers in Systems Neuroscience). Dysregulation of these pathways is a hallmark of functional gastrointestinal disorders, such as irritable bowel syndrome (IBS), and is increasingly linked to psychiatric conditions like anxiety and depression (Konturek et al., 2011, Journal of Physiology and Pharmacology). While the pathway itself is not a single molecular target, it contains numerous specific targets—including CRF receptors and serotonin transporters—that are the focus of therapeutic intervention to treat stress-related disorders. Understanding these pathways is crucial for developing holistic treatments that address the interplay between mental health and digestive function.

Other names
Gut-brain axisMicrobiota-gut-brain axisBrain-gut axisHPA-gut axis
02

Mechanism of action

Modulation of the bidirectional communication between the central nervous system and the enteric nervous system via the HPA axis, autonomic nervous system, and neuro-immune signaling pathways (Carabotti et al., 2015, Annals of Gastroenterology).

03

Biological functions

Signal transductionImmune responseNeuroendocrine signalingStress response regulationGastrointestinal motility regulationOther
04

Disease associations

InflammationIrritable bowel syndrome (IBS)AnxietyDepressionInflammatory bowel disease (IBD)Other
05

Safety considerations

Broad systemic effectsPotential for psychiatric adverse eventsComplexity of targeting bidirectional feedback loopsVariable patient response due to microbiota diversity
06

Interacting drugs

Pexacerfont

4 more in the full profile.

07

Biomarkers

Salivary cortisolPlasma corticotropin-releasing factor (CRF)Heart rate variability (HRV)Fecal calprotectinFecal microbiota composition

Beyond the preview

Go deeper on Central and gut–brain stress-related pathways (GBA) (GBA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Central and gut–brain stress-related pathways (GBA) (GBA).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call